Incremental prognostic value and underlying biological pathways of radiomics patterns in medulloblastoma.
EBioMedicine
; 61: 103093, 2020 Nov.
Article
em En
| MEDLINE
| ID: mdl-33096488
ABSTRACT
BACKGROUND:
To develop a radiomics signature for predicting overall survival (OS)/progression-free survival (PFS) in patients with medulloblastoma (MB), and to investigate the incremental prognostic value and biological pathways of the radiomics patterns.METHODS:
A radiomics signature was constructed based on magnetic resonance imaging (MRI) from a training cohort (n = 83), and evaluated on a testing cohort (n = 83). Key pathways associated with the signature were identified by RNA-seq (GSE151519). Prognostic value of pathway genes was assessed in a public GSE85218 cohort.FINDINGS:
The radiomics-clinicomolecular signature predicted OS (C-index 0.762) and PFS (C-index 0.697) better than either the radiomics signature (C-index OS 0.649; PFS 0.593) or the clinicomolecular signature (C-index OS 0.725; PFS 0.691) alone, with a better calibration and classification accuracy (net reclassification improvement OS 0.298, P = 0.022; PFS 0.252, P = 0.026). Nine pathways were significantly correlated with the radiomics signature. Average expression value of pathway genes achieved significant risk stratification in GSE85218 cohort (log-rank P = 0.016).INTERPRETATION:
This study demonstrated radiomics signature, which associated with dysregulated pathways, was an independent parameter conferring incremental value over clinicomolecular factors in survival predictions for MB patients.FUNDING:
A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imageamento por Ressonância Magnética
/
Biomarcadores
/
Transdução de Sinais
/
Meduloblastoma
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article